Insider Stock Trading History of Shaaltiel Yoseph


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shaaltiel Yoseph since year 2005. The trader's CIK number is 1385118. At the time of this reporting, Shaaltiel Yoseph is the Executive VP, R&D of Protalix Biotherapeutics, Inc. . (stock ticker symbol PLX). See this page for all insider trading activities at Protalix Biotherapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Shaaltiel Yoseph since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-09-15 PLX Protalix Biotherapeutics, Inc. Option Ex 122,162 .00 122
2012-05-02 PLX Protalix Biotherapeutics, Inc. Sale 300,000 7.13 2,139,000
2010-08-05 PLX Protalix Biotherapeutics, Inc. Sale 48,408 7.00 338,856
2010-08-06 PLX Protalix Biotherapeutics, Inc. Sale 4,619 7.00 32,333
2010-06-21 PLX Protalix Biotherapeutics, Inc. Sale 52,973 7.00 370,811
2010-04-29 PLX Protalix Biotherapeutics, Inc. Sale 12,691 7.00 88,837
2010-04-14 PLX Protalix Biotherapeutics, Inc. Sale 1,309 7.00 9,163
2010-03-23 PLX Protalix Biotherapeutics, Inc. Sale 127,300 7.02 893,646
2010-03-24 PLX Protalix Biotherapeutics, Inc. Sale 202,700 7.08 1,435,116
2010-03-25 PLX Protalix Biotherapeutics, Inc. Sale 50,000 7.00 350,000
2009-10-16 PLX Protalix Biotherapeutics, Inc. Sale 25,680 9.39 241,135
2009-10-19 PLX Protalix Biotherapeutics, Inc. Sale 43,120 9.43 406,621
2009-10-15 PLX Protalix Biotherapeutics, Inc. Sale 31,200 9.39 292,968
2009-07-06 PLX Protalix Biotherapeutics, Inc. Sale 100,000 5.04 504,000
2009-05-13 PLX Protalix Biotherapeutics, Inc. Sale 20,000 3.51 70,200
2009-05-14 PLX Protalix Biotherapeutics, Inc. Sale 10,000 3.85 38,500
2009-03-13 PLX Protalix Biotherapeutics, Inc. Sale 8,300 2.18 18,094
2007-12-17 PLX Protalix Biotherapeutics, Inc. Buy 5,000 3.35 16,750
2007-12-18 PLX Protalix Biotherapeutics, Inc. Buy 5,100 3.38 17,212
2007-12-19 PLX Protalix Biotherapeutics, Inc. Buy 4,800 3.40 16,320
2007-12-05 PLX Protalix Biotherapeutics, Inc. Buy 15,100 3.12 47,112

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shaaltiel Yoseph (Executive VP, R&D of Protalix Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.